Boston Scientific Corp
(NYSE: BSX)
9.40
-0.14
-1.47%
-0.14
-1.47%
MORE ON BSX
COMPANY INFORMATION
| Exchange: | New York Stock Exchange |
| Stock: | Boston Scientific, Inc. |
| Industry: | Medical Devices |
| Employees: | 24,000 |
DESCRIPTION
| Boston Scientific, Inc., is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company’s products were offered for sale by seven core businesses - Interventional Cardiology, CRM, Endoscopy, Peripheral Interventions, Urology/Women’s Health, Neuromodulation, and Electrophysiology. The Company derives 33 percent of its sales from its Interventional Cardiology business, 27 percent of its sales from its CRM business, 16 percent of its sales from its Endoscopy business, 10 percent of its sales from its Peripheral Interventions business, six percent of its sales from its Urology/Women’s Health business, four percent of its sales from its Neuromodulation business, and two percent of its sales from its Electrophysiology business. It develops, manufactures and markets a variety of implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, including: Implantable cardiac defibrillator systems used to detect and treat abnormally fast heart rhythms that could result in sudden cardiac death, including implantable cardiac resynchronization therapy defibrillator systems used to treat heart failure; and Implantable pacemaker systems used to manage slow or irregular heart rhythms, including implantable cardiac resynchronization therapy pacemaker systems used to treat heart failure. Within the Company’s Electrophysiology business, it offers medical devices for the diagnosis and treatment of cardiac arrhythmias. Included in its product offerings are RF generators, intracardiac ultrasound and steerable ablation catheters, and diagnostic catheters. The Company’s main competitors include Abbott Laboratories; Medtronic, Inc.; St. Jude Medical, Inc.; and Johnson & Johnson as well as a wide range of medical device companies that sell a single or limited number of competitive products or participate in only a specific market segment. It also faces competition from non-medical device companies, such as pharmaceutical companies, which may offer alternative therapies for disease states intended to be treated using its products. The medical devices that the Company manufactures and markets are subject to regulation by numerous regulatory bodies, including the FDA and comparable international regulatory agencies. |
DATA PROVIDERS
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
RECENT QUOTES
WATCHLIST
You're not signed in
You’re not signed in to MSN Money, so you’re seeing the Watchlist that is tied to your computer. For a more consistent Watchlist experience, sign in to MSN Money.
Learn more
Sponsored by:
MARKET UPDATE
[BRIEFING.COM] Equities ended on their lows with the S&P 500 down 1.4%. The S&P entered today's session with a week-to-date gain of 1.5% as investors expected reassuring words from today's Federal Open Market Committee Statement. Stocks traded with s
...
More
MORE MARKET NEWS
Sponsored by: